Whereas the transformation of gentamicin C,a to C2b would require a single enzymatic reaction, 6 '-N-methylation, that of sisomicin to C2b would require (4'-5')-reduction as an additional enzymatic reaction. Micromonospora rhodorangea NRRL 5326 has been shown to produce antibiotic G-418 (6'-C-methylgentamicin X2).
Since it was thought this strain might lack the (4'-5')-reduction activity, we chose this strain rather than M. purpurea SC 1124 to transform sisomicin to 6'-N-methylsisomicin (antibiotic G-52 [1, 5] . Unexpectedly, however, M. rhodorangea.5326, like M. purpurea 1124, yielded gentamicin C2b (Fig. 1) . A 10-liter preparative fermentation was carried out to study the M. rhodorangea strain-mediated biotransformation in detail. The results of the examination of the biotransformation products are reported in this paper.
MATERIALS AND METHODS Strain. M. rhodorangea NRRL 5326 was used throughout the investigation.
Shake flask fermentation and isolation of the crude product. Shake flask fermentations were performed in 50 ml of medium (4) in 300-ml Erlenmeyer flasks, each containing 50 mg of sisomicin sulfate and 20 ZiCi of L-[methyl-'4C]methionine added at various times. Previously described procedures (3, 4) were used for isolation of crude product.
Tank fermentation and isolation of the crude product. A 500-ml amount of the 2-day inoculum was added to 10 liters of fermentation medium in a 14-liter fermentor (New Brunswick Scientific, model MF-114), and the fermentation broth was stirred at 28°C at 350 to 500 rpm with a continuous air flow of 3.5 to 5 liters/min (3) . Approximately 20 ml of antifoam (Dow Corning B emulsion) was added automatically during the entire fermentation. One gram of sisomicin sulfate, equivalent to 646 mg of free base, was added 48 h after inoculation; the fermentation broth was harvested after an additional 120-h incubation.
The harvested beer (8.8 liter, pH 6.85) was acidified to pH 2 with concentrated H2SO4, stirred for 1 h, and filtered. The filtrate was neutralized with concentrated NH40H, and 55.5 g of oxalic acid was added to precipitate calcium. The preparation was refiltered, and the filtrate (pH 1.8) was reneutralized with concentrated NH40H. A 100-g portion of IRC-50 resin (NH4+ cycle) was added to the neutralized filtrate, and the mixture (resin plus filtrate) was stirred for 1 h at room temperature. The clean supernatant was poured off, and the resin was washed with distilled water and eluted four times with 1.8, 1.5, 1.0, and 1.0 liter of 2 N NH4OH, respectively. Combined eluates were concentrated, filtered, and lyophilized to yield the crude product.
Column chromatography. An 800-g amount of silica gel (GF 254, type 60 EM) was suspended in a mixture of chloroform-isopropanol-17% ammonia (2:1:1), shaken for 0.5 h, and packed into a column (45 by 7.5 cm). The crude product (1.281 g) was suspended in the same solvent mixture, added to the column, and eluted with the solvent mixture at a flow rate of 0.33 ml/min for the first 274 isolated. Fraction 1 was bioinactive, and fraction 12 was found to contain 127 mg ofantibiotic G-418. Fraction 2 (6.4 mg) and fraction 3 (2.8 mg) were shown, respectively, to be a mixture of gentamicin C2b and an unidentified antibiotic, which was chromatographically less polar than gentamicin C1.
Identification of fraction 6. The mass and proton magnetic resonance spectra of a decarbonated sample from fraction 6 (gentamicin C2b) were identical to those reported by Daniels and co-workers (2) .
Time course study of incorporation of [methyl-"4C]methionine. The rates of incoxporation of the 14CH3 label into both gentamicin C2b and antibiotic G-418 were highest during the early incubation (0.25 to 6 h) with the organism and leveled off in about 24 h. The ratio of the incorporation of the "CH3 label into the gentamicin C2b to that incorporated into antibiotic G-418 was approximately 1:2.6 (Fig. 3) .
Attempts to monitor the (4'-5')-reduction 45, 1976 ) isolated the gentamicin C1 from an L-[methyl-13C]methionine-feeding fernentation. They showed that the carbon enrichments for the 3"-N-, 6'-N-, 4"-C-, and 6'-Cmethyl groups were respectively, 2.65, 2.93, 3.07, and 2.26 times greater than in natural abundance and concluded that the carbon atoms of the gentamicin methyl groups are derived from methionine. Therefore, the 6'-Nmethylation of sisomicin by the antibiotic G-418-producing strain would have to compete with the 3"-N-, 4'-C-, and 6'-C-methylation for the methyl groups, resulting in a low percentage of incorporation of the 14CH3 label into the gentamicin C2b, as seen in the above-mentioned results.
From a preparative biotransformation of 646 mg of sisomicin by M. rhodorangea NRRL 5326, we have isolated 30.5 mg (or 5%) of gentamicin C2b. We were unsuccessful in following 
